188 related articles for article (PubMed ID: 25465301)
21. The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Takemoto K; Teishima J; Kohada Y; Ikeda K; Nagamatsu H; Goriki A; Inoue S; Hayashi T; Kajiwara M; Matsubara A
Anticancer Res; 2020 Aug; 40(8):4787-4793. PubMed ID: 32727806
[TBL] [Abstract][Full Text] [Related]
22. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I
J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452
[TBL] [Abstract][Full Text] [Related]
23. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
Fairey AS; Daneshmand S; Wang L; Schuckman A; Lieskovsky G; Djaladat H; Cai J; Miranda G; Skinner EC
Urol Oncol; 2014 Feb; 32(2):110-6. PubMed ID: 23499168
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
25. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
Mitra AP; Fairey AS; Skinner EC; Boorjian SA; Frank I; Schoenberg MP; Bivalacqua TJ; Hyndman ME; Reese AC; Steinberg GD; Large MC; Hulsbergen-van de Kaa CA; Bruins HM; Daneshmand S
Urol Oncol; 2019 Jan; 37(1):48-56. PubMed ID: 30446450
[TBL] [Abstract][Full Text] [Related]
26. Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy.
Moschini M; Dell'Oglio P; Luciano' R; Gandaglia G; Soria F; Mattei A; Klatte T; Damiano R; Shariat SF; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Urol Oncol; 2017 Jun; 35(6):335-341. PubMed ID: 28087131
[TBL] [Abstract][Full Text] [Related]
27. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
28. Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology.
Rice KR; Koch MO; Kao CS; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Bihrle R; Cheng L
Urol Oncol; 2015 Jan; 33(1):20.e23-20.e29. PubMed ID: 25047418
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF
BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039
[TBL] [Abstract][Full Text] [Related]
30. The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy.
Stroman L; Nair R; Russell B; Malik N; Desai A; Chandra A; Thurairaja R; Dasgupta P; Khan MS; Malde S
BJU Int; 2019 Sep; 124(3):418-423. PubMed ID: 30740862
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
[TBL] [Abstract][Full Text] [Related]
32. The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?
Monn MF; Kaimakliotis HZ; Cary KC; Bihrle R; Pedrosa JA; Masterson TA; Foster RS; Gardner TA; Cheng L; Koch MO
BJU Int; 2015 Aug; 116(2):236-40. PubMed ID: 25060358
[TBL] [Abstract][Full Text] [Related]
33. Contemporary bladder cancer: variant histology may be a significant driver of disease.
Monn MF; Kaimakliotis HZ; Pedrosa JA; Cary KC; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2015 Jan; 33(1):18.e15-18.e20. PubMed ID: 25459358
[TBL] [Abstract][Full Text] [Related]
34. Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
Linder BJ; Frank I; Cheville JC; Thompson RH; Thapa P; Tarrell RF; Boorjian SA
J Urol; 2013 May; 189(5):1670-5. PubMed ID: 23142686
[TBL] [Abstract][Full Text] [Related]
35. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Variant Histology in Patients with Urothelial Carcinoma Treated with Radical Cystectomy: Can We Predict the Presence of Variant Histology?
Prijovic N; Acimovic M; Santric V; Stankovic B; Nikic P; Vukovic I; Radovanovic M; Kovacevic L; Nale P; Babic U
Curr Oncol; 2023 Sep; 30(10):8841-8852. PubMed ID: 37887538
[TBL] [Abstract][Full Text] [Related]
37. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
40. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
